Determining the smallest worthwhile difference of beta-3 agonist treatment for overactive bladder: a benefit-harm trade-off study.

Saved in:
Bibliographic Details
Title: Determining the smallest worthwhile difference of beta-3 agonist treatment for overactive bladder: a benefit-harm trade-off study.
Authors: Omae K; Department of Innovative Research and Education for Clinicians and Trainees (DiRECT), Fukushima Medical University Hospital, 1 Hikarigaoka, Fukushima, 960-1295, Japan. omae416@fmu.ac.jp.; Department of Health Promotion and Human Behavior, School of Public Health, Kyoto University Graduate School of Medicine, Kyoto, Japan. omae416@fmu.ac.jp., Luo Y; Department of Next-Generation Organ Transplantation, The University of Tokyo Graduate School of Medicine, Tokyo, Japan.; Population Health and Policy Research Unit, Center for Medical Education and Internationalization, Kyoto University Graduate School of Medicine, Kyoto, Japan., Sahker E; Department of Health Promotion and Human Behavior, School of Public Health, Kyoto University Graduate School of Medicine, Kyoto, Japan.; Population Health and Policy Research Unit, Center for Medical Education and Internationalization, Kyoto University Graduate School of Medicine, Kyoto, Japan., Tajika A; Department of Health Promotion and Human Behavior, School of Public Health, Kyoto University Graduate School of Medicine, Kyoto, Japan., Kataoka Y; Department of Healthcare Epidemiology, School of Public Health, Kyoto University Graduate School of Medicine, Kyoto, Japan.; Scientific Research Works Peer Support Group (SRWS-PSG), Osaka, Japan.; Department of Internal Medicine, Kyoto Min-Iren Asukai Hospital, Kyoto, Japan., Sekido N; Department of Urology, Toho University Ohashi Medical Center, Meguro, Japan., Furukawa TA; Department of Health Promotion and Human Behavior, School of Public Health, Kyoto University Graduate School of Medicine, Kyoto, Japan.; Office of Institutional Advancement and Communications, Kyoto University, Kyoto, Japan.
Source: World journal of urology [World J Urol] 2026 Feb 16; Vol. 44 (1), pp. 175. Date of Electronic Publication: 2026 Feb 16.
Publication Type: Journal Article
Journal Info: Publisher: Springer International Country of Publication: Germany NLM ID: 8307716 Publication Model: Electronic Cited Medium: Internet ISSN: 1433-8726 (Electronic) Linking ISSN: 07244983 NLM ISO Abbreviation: World J Urol Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Description
ISSN:1433-8726
DOI:10.1007/s00345-026-06274-8